Aprea Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aprea Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aprea Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aprea Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $30 | 11 | 2.73 |
| 2024-06-30 | $48 | 12 | 4.08 |
| 2023-12-31 | $24 | 5 | 4.80 |
| 2023-09-30 | $17 | 4 | 4.25 |